Usher Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Usher syndrome is an inherited condition characterized by hearing impairment and progressive vision loss. The major symptoms of Usher syndrome are hearing loss and an eye disorder called retinitis pigmentosa. Risk factors include retinal degeneration and prolonged and unprotected exposure to sunlight may accelerate vision loss. Treatment includes cochlear implants, hearing aids, and Vitamin A supplementation.
The Usher syndrome pipeline market research report provides comprehensive information on the therapeutics under development for Usher syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Usher syndrome and features dormant and discontinued projects.
Usher Syndrome Pipeline Products Market Segmentation by Targets
The key targets in the Usher syndrome pipeline products market are Usherin, Clarin 1, Harmonin, Unconventional Myosin VIIa, and Usher syndrome Type 1G Protein. Usherin is the leading target in the pipeline.
Usher Syndrome Pipeline Products Market Analysis by Targets
For more target insights into the Usher syndrome pipeline products market, download a free report sample
Usher Syndrome Pipeline Products Market Segmentation by Mechanisms of Action
The key mechanisms of action in the Usher syndrome pipeline products market are Usherin Activator, Clarin 1 Activator, Harmonin Activator, Unconventional Myosin VIIa Activator, and Usher syndrome Type 1G Protein Activator. Usherin Activator is the leading MoA in the pipeline market.
Usher Syndrome Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights into the Usher syndrome pipeline products market, download a free report sample
Usher Syndrome Pipeline Products Market Segmentation by Routes of Administration
The key routes of administration in the Usher syndrome pipeline products market are intravitreal, intraocular, and parenteral. Intravitreal is the most preferred route for administration.
Usher Syndrome Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights into the Usher syndrome pipeline products market, download a free report sample
Usher Syndrome Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the Usher syndrome pipeline products market are gene therapy, antisense oligonucleotide, small molecule, and oligonucleotide. The leading molecule is gene therapy.
Usher Syndrome Pipeline Products Market Analysis by Molecule Types
For more molecule type insights into the Usher syndrome pipeline products market, download a free report sample
Usher Syndrome Pipeline Products Market - Competitive Landscape
Some of the leading companies in the Usher syndrome pipeline products market are Odylia Therapeutics Inc, ProQR Therapeutics NV, GeneToBe LLC, Akouos Inc, Atsena Therapeutics Inc, Clearside BioMedical Inc, Editas Medicine Inc, Eloxx Pharmaceuticals Inc, and Ionis Pharmaceuticals Inc among others. Odylia Therapeutics Inc is the leading company in the Usher syndrome pipeline products market.
Usher Syndrome Pipeline Products Market Analysis by Companies
To know more about the leading players in the Usher syndrome pipeline products market, download a free report sample
Usher Syndrome Pipeline Products Market Report Overview
| Key Targets | Usherin, Clarin 1, Harmonin, Unconventional Myosin VIIa, and Usher syndrome Type 1G Protein |
| Key Mechanisms of Action | Usherin Activator, Clarin 1 Activator, Harmonin Activator, Unconventional Myosin VIIa Activator, and Usher syndrome Type 1G Protein Activator |
| Key Routes of Administration | Intravitreal, Intraocular, And Parenteral |
| Key Molecule Type | Gene Therapy, Antisense Oligonucleotide, Small Molecule, and Oligonucleotide |
| Leading Companies | Odylia Therapeutics Inc, ProQR Therapeutics NV, GeneToBe LLC, Akouos Inc, Atsena Therapeutics Inc, Clearside BioMedical Inc, Editas Medicine Inc, Eloxx Pharmaceuticals Inc, and Ionis Pharmaceuticals Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Usher syndrome.
- The pipeline guide reviews pipeline therapeutics for Usher syndrome by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Usher syndrome therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Usher syndrome therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Usher syndrome
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Usher syndrome.
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding the Usher syndrome pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Atsena Therapeutics Inc
Clearside BioMedical Inc
Editas Medicine Inc
Eloxx Pharmaceuticals Inc
GeneToBe LLC
Ionis Pharmaceuticals Inc
IVERIC bio Inc
Locanabio Inc
Nanoscope Therapeutics Inc
Odylia Therapeutics Inc
ProQR Therapeutics NV
Saliogen Therapeutics Inc
Wave Life Sciences Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Usher syndrome pipeline products market?
The key targets in the Usher syndrome pipeline products market are Usherin, Clarin 1, Harmonin, Unconventional Myosin VIIa, and Usher syndrome Type 1G Protein.
-
What are the key mechanisms of action in the Usher syndrome pipeline products market?
The key mechanisms of action in the Usher syndrome pipeline products market are Usherin Activator, Clarin 1 Activator, Harmonin Activator, Unconventional Myosin VIIa Activator, and Usher syndrome Type 1G Protein Activator.
-
What are the key routes of administration in the Usher syndrome pipeline products market?
The key routes of administration in the Usher syndrome pipeline products market are intravitreal, intraocular, and parenteral.
-
What are the key molecule types in the Usher syndrome pipeline products market?
The key molecule types in the Usher syndrome pipeline products market are gene therapy, antisense oligonucleotide, small molecule, and oligonucleotide.
-
Which are the leading companies in the Usher syndrome pipeline products market?
Some of the leading companies in the Usher syndrome pipeline products market are Odylia Therapeutics Inc, ProQR Therapeutics NV, GeneToBe LLC, Akouos Inc, Atsena Therapeutics Inc, Clearside BioMedical Inc, Editas Medicine Inc, Eloxx Pharmaceuticals Inc, and Ionis Pharmaceuticals Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Other Diseases reports